NCT01631552 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 81
- group Id
- BG001
- value
- 402
- group Id
- BG002
- value
- 9
- group Id
- BG003
- value
- 3
- group Id
- BG004
- value
- 495
- units
- Participants
- groups
- description
- Participants received sacituzumab govitecan-hziy 8 mg/kg of body weight via IV infusion on Days 1 and 8 of a 21-day treatment cycle until disease progression or unacceptable toxicity.
- id
- BG000
- title
- SG 8mg/kg
- description
- Participants received sacituzumab govitecan-hziy 10 mg/kg of body weight via IV infusion on Days 1 and 8 of a 21-day treatment cycle until disease progression or unacceptable toxicity.
- id
- BG001
- title
- SG 10 mg/kg
- description
- Participants received sacituzumab govitecan-hziy 12 mg/kg of body weight via IV infusion on Days 1 and 8 of a 21-day treatment cycle until disease progression or unacceptable toxicity.
- id
- BG002
- title
- SG 12 mg/kg
- description
- Participants received sacituzumab govitecan-hziy 18 mg/kg of body weight via IV infusion on Days 1 and 8 of a 21-day treatment cycle until disease progression or unacceptable toxicity.
- id
- BG003
- title
- SG 18 mg/kg
- description
- Total of all reporting groups
- id
- BG004
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 10.91
- value
- 61.1
- group Id
- BG001
- spread
- 11.28
- value
- 59.8
- group Id
- BG002
- spread
- 10.53
- value
- 59.1
- group Id
- BG003
- spread
- 4.00
- value
- 56.0
- group Id
- BG004
- spread
- 11.17
- value
- 60.0
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 46
- group Id
- BG001
- value
- 281
- group Id
- BG002
- value
- 6
- group Id
- BG003
- value
- 1
- group Id
- BG004
- value
- 334
- title
- Female
- measurements
- group Id
- BG000
- value
- 35
- group Id
- BG001
- value
- 121
- group Id
- BG002
- value
- 3
- group Id
- BG003
- value
- 2
- group Id
- BG004
- value
- 161
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 67
- group Id
- BG001
- value
- 329
- group Id
- BG002
- value
- 6
- group Id
- BG003
- value
- 3
- group Id
- BG004
- value
- 405
- title
- White
- measurements
- group Id
- BG000
- value
- 6
- group Id
- BG001
- value
- 19
- group Id
- BG002
- value
- 2
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 27
- title
- Black
- measurements
- group Id
- BG000
- value
- 4
- group Id
- BG001
- value
- 13
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 18
- title
- Asian
- measurements
- group Id
- BG000
- value
- 4
- group Id
- BG001
- value
- 41
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 45
- title
- Other
- title
- Race
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race/Ethnicity, Customized
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 4
- group Id
- BG001
- value
- 16
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 20
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 77
- group Id
- BG001
- value
- 386
- group Id
- BG002
- value
- 9
- group Id
- BG003
- value
- 3
- group Id
- BG004
- value
- 475
- title
- Not Hispanic or Latino
- title
- Ethnicity
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race/Ethnicity, Customized
- unit Of Measure
- Participants
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 81
- group Id
- BG001
- value
- 402
- group Id
- BG002
- value
- 9
- group Id
- BG003
- value
- 3
- group Id
- BG004
- value
- 495
- units
- Participants
- groups
- description
- Participants received sacituzumab govitecan-hziy 8 mg/kg of body weight via IV infusion on Days 1 and 8 of a 21-day treatment cycle until disease progression or unacceptable toxicity.
- id
- BG000
- title
- SG 8mg/kg
- description
- Participants received sacituzumab govitecan-hziy 10 mg/kg of body weight via IV infusion on Days 1 and 8 of a 21-day treatment cycle until disease progression or unacceptable toxicity.
- id
- BG001
- title
- SG 10 mg/kg
- description
- Participants received sacituzumab govitecan-hziy 12 mg/kg of body weight via IV infusion on Days 1 and 8 of a 21-day treatment cycle until disease progression or unacceptable toxicity.
- id
- BG002
- title
- SG 12 mg/kg
- description
- Participants received sacituzumab govitecan-hziy 18 mg/kg of body weight via IV infusion on Days 1 and 8 of a 21-day treatment cycle until disease progression or unacceptable toxicity.
- id
- BG003
- title
- SG 18 mg/kg
- description
- Total of all reporting groups
- id
- BG004
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 10.91
- value
- 61.1
- group Id
- BG001
- spread
- 11.28
- value
- 59.8
- group Id
- BG002
- spread
- 10.53
- value
- 59.1
- group Id
- BG003
- spread
- 4.00
- value
- 56.0
- group Id
- BG004
- spread
- 11.17
- value
- 60.0
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 46
- group Id
- BG001
- value
- 281
- group Id
- BG002
- value
- 6
- group Id
- BG003
- value
- 1
- group Id
- BG004
- value
- 334
- title
- Female
- measurements
- group Id
- BG000
- value
- 35
- group Id
- BG001
- value
- 121
- group Id
- BG002
- value
- 3
- group Id
- BG003
- value
- 2
- group Id
- BG004
- value
- 161
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 67
- group Id
- BG001
- value
- 329
- group Id
- BG002
- value
- 6
- group Id
- BG003
- value
- 3
- group Id
- BG004
- value
- 405
- title
- White
- measurements
- group Id
- BG000
- value
- 6
- group Id
- BG001
- value
- 19
- group Id
- BG002
- value
- 2
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 27
- title
- Black
- measurements
- group Id
- BG000
- value
- 4
- group Id
- BG001
- value
- 13
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 18
- title
- Asian
- measurements
- group Id
- BG000
- value
- 4
- group Id
- BG001
- value
- 41
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 45
- title
- Other
- title
- Race
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race/Ethnicity, Customized
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 4
- group Id
- BG001
- value
- 16
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 20
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 77
- group Id
- BG001
- value
- 386
- group Id
- BG002
- value
- 9
- group Id
- BG003
- value
- 3
- group Id
- BG004
- value
- 475
- title
- Not Hispanic or Latino
- title
- Ethnicity
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race/Ethnicity, Customized
- unit Of Measure
- Participants
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Not medical advice
Triangle